Medicover AB (publ) (MCVEY) Q1 2026 Earnings Call April 29, 2026 3:30 AM EDT
Company Participants
John Stubbington – Chief Executive Officer
Anand Patel – Chief Financial Officer
Conference Call Participants
Philip Ekengren – ABG Sundal Collier Holding ASA, Research Division
Mattias Vadsten – SEB, Research Division
Kristofer Liljeberg-Svensson – DNB Carnegie, Research Division
Kane Slutzkin – Deutsche Bank AG, Research Division
Darius Saftoiu – Jefferies LLC, Research Division
Presentation
Operator
Welcome to the Medicover Q1 2026 Report Presentation. [Operator Instructions]
Now I will hand the conference over to the speakers, CEO, John Stubbington; and CFO, Anand Patel. Please go ahead.
John Stubbington
Chief Executive Officer
Good morning, everybody. Welcome to our Q1 presentation. I think we’ve had a good first quarter. It’s been a consistent and solid sort of position. We’ve got good momentum going on in the business with strong organic growth of 10.3%. This is our fifth consecutive quarter of improved margins year-on-year, which we’re delighted with. There’s been a few negative headwinds that have hit us. I don’t think we need to talk about that too much. I think as a team, we’ve sort of navigated that well. And it shows the strength of our model. So it’s pleasing to see the position that we’ve come out with despite all of that.
India, India has shown some strong momentum. We expected that. We talked about that a lot in previous quarters in terms of what we’ve done to be able to get a bigger level of growth and more momentum as we go towards IPO. So we’re very positive with that particular result in the quarter, and we fully expect it to progress as we go through coming quarters.
Very robust performance in Diagnostic Services, very pleased for the team, done an excellent job and our fee-for-service development is increasing in
